US Stock MarketDetailed Quotes

TWST Twist Bioscience

Watchlist
  • 41.660
  • +0.550+1.34%
Close Nov 21 16:00 ET
  • 41.710
  • +0.050+0.12%
Pre 06:21 ET
2.47BMarket Cap-11572P/E (TTM)

Twist Bioscience Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
55.01%-64.09M
26.00%-15.32M
72.76%-6.38M
56.14%-19.42M
57.51%-22.97M
-14.54%-142.47M
-1,534.10%-20.7M
31.39%-23.41M
-4.60%-44.29M
-15.90%-54.07M
Net income from continuing operations
-2.01%-208.73M
25.06%-34.66M
-49.09%-85.57M
23.10%-45.49M
-2.83%-43.01M
6.08%-204.62M
9.53%-46.24M
5.16%-57.4M
2.49%-59.16M
8.21%-41.82M
Depreciation and amortization
7.24%31.43M
-21.69%6.66M
-2.23%8.3M
18.16%8.3M
54.40%8.17M
77.49%29.31M
71.65%8.5M
91.04%8.49M
77.12%7.03M
68.00%5.29M
Other non cash items
160.06%1.93M
-12.69%1.47M
54.80%-334K
184.47%484K
108.68%312K
-144.33%-3.22M
-90.50%1.69M
77.23%-739K
89.73%-573K
-117.55%-3.59M
Change In working capital
1,627.35%15.41M
-358.50%-1.14M
4.55%12.56M
287.27%3.46M
104.58%532K
81.16%-1.01M
-82.53%441K
141.12%12.02M
20.36%-1.85M
-10.17%-11.62M
-Change in receivables
295.46%8.44M
-63.02%-2.95M
-27.88%4M
83.38%-657K
296.63%8.06M
55.10%-4.32M
-373.72%-1.81M
186.07%5.54M
-117.98%-3.95M
-101.67%-4.1M
-Change in inventory
10.33%7.99M
2.77%4.41M
-46.81%1.89M
-89.60%486K
122.74%1.2M
196.05%7.24M
15.89%4.29M
129.35%3.56M
207.45%4.68M
37.40%-5.28M
-Change in prepaid assets
109.17%382K
125.41%567K
168.31%235K
268.12%696K
5.18%-1.12M
-63.31%-4.17M
-1,305.95%-2.23M
74.12%-344K
68.54%-414K
-1,193.41%-1.18M
-Change in payables and accrued expense
147.13%485K
-249.32%-2.65M
356.13%5.54M
270.58%3.98M
-278.14%-6.38M
-107.09%-1.03M
-77.55%1.78M
-80.16%1.22M
-163.82%-2.33M
46.98%-1.69M
-Change in other current assets
-68.68%431K
-112.58%-41K
204.49%163K
-98.73%9K
-39.88%300K
-81.08%1.38M
-26.58%326K
-105.28%-156K
10.12%707K
-84.56%499K
-Change in other current liabilities
-2,045.37%-2.32M
75.46%-468K
-66.68%734K
-99.06%-1.06M
-1,312.70%-1.53M
98.55%-108K
81.62%-1.91M
3.82%2.2M
-161.20%-530K
470.59%126K
Cash from discontinued investing activities
Operating cash flow
55.01%-64.09M
26.00%-15.32M
72.76%-6.38M
56.14%-19.42M
57.51%-22.97M
-14.54%-142.47M
-1,534.10%-20.7M
31.39%-23.41M
-4.60%-44.29M
-15.90%-54.07M
Investing cash flow
Cash flow from continuing investing activities
-106.07%-3.07M
42.81%-1.29M
-103.81%-711K
-112.73%-5.24M
159.75%4.17M
121.73%50.61M
-180.74%-2.25M
348.47%18.67M
409.61%41.16M
96.92%-6.97M
Net PPE purchase and sale
81.73%-5.08M
16.34%-2M
78.60%-965K
93.34%-603K
87.26%-1.51M
72.73%-27.78M
85.46%-2.39M
88.91%-4.51M
71.68%-9.05M
7.50%-11.82M
Net business purchase and sale
--0
----
----
----
----
--0
----
----
----
----
Net investment purchase and sale
-97.44%2.01M
391.10%717K
-98.90%254K
-109.23%-4.64M
16.86%5.67M
166.91%78.39M
-99.42%146K
-48.27%23.18M
168.86%50.21M
102.36%4.85M
Cash from discontinued investing activities
Investing cash flow
-106.07%-3.07M
42.81%-1.29M
-103.81%-711K
-112.73%-5.24M
159.75%4.17M
121.73%50.61M
-180.74%-2.25M
348.47%18.67M
409.61%41.16M
96.92%-6.97M
Financing cash flow
Cash flow from continuing financing activities
656.31%6.89M
720.59%3.63M
539.94%2.91M
19.87%1.83M
-272.91%-1.47M
-99.66%911K
-64.35%442K
49.58%-661K
-99.44%1.53M
60.93%-395K
Net issuance payments of debt
--0
----
----
----
----
--0
----
----
----
----
Net common stock issuance
9.76%-3.98M
99.29%-8K
99.31%-7K
-21.71%-1.54M
-142.64%-2.42M
-101.68%-4.41M
30.50%-1.13M
51.11%-1.01M
-100.47%-1.26M
60.95%-999K
Proceeds from stock option exercised by employees
104.38%10.87M
131.23%3.64M
725.78%2.92M
20.70%3.36M
57.45%951K
-46.97%5.32M
-45.15%1.57M
-53.74%353K
-15.29%2.79M
-80.55%604K
Cash from discontinued financing activities
Financing cash flow
656.31%6.89M
720.59%3.63M
539.94%2.91M
19.87%1.83M
-272.91%-1.47M
-99.66%911K
-64.35%442K
49.58%-661K
-99.44%1.53M
60.93%-395K
Net cash flow
Beginning cash position
-23.93%289.28M
-22.38%242.04M
-22.47%246.22M
-15.66%269.12M
-23.93%289.28M
-18.64%380.26M
-17.46%311.84M
-22.39%317.56M
65.16%319.09M
-18.64%380.26M
Current changes in cash
33.73%-60.28M
42.34%-12.98M
22.62%-4.18M
-1,324.52%-22.84M
66.99%-20.28M
-4.81%-90.95M
-916.73%-22.51M
82.72%-5.4M
-100.74%-1.6M
77.60%-61.44M
Effect of exchange rate changes
566.67%126K
252.08%73K
100.63%2K
-189.04%-65K
-56.72%116K
91.54%-27K
84.91%-48K
-204.76%-320K
247.62%73K
222.89%268K
End cash Position
-20.79%229.13M
-20.79%229.13M
-22.38%242.04M
-22.47%246.22M
-15.66%269.12M
-23.93%289.28M
-23.93%289.28M
-17.46%311.84M
-22.39%317.56M
65.16%319.09M
Free cash flow
59.37%-69.17M
25.00%-17.32M
73.70%-7.34M
62.46%-20.03M
62.85%-24.48M
24.75%-170.25M
-30.28%-23.1M
62.66%-27.92M
28.22%-53.34M
-10.87%-65.89M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 55.01%-64.09M26.00%-15.32M72.76%-6.38M56.14%-19.42M57.51%-22.97M-14.54%-142.47M-1,534.10%-20.7M31.39%-23.41M-4.60%-44.29M-15.90%-54.07M
Net income from continuing operations -2.01%-208.73M25.06%-34.66M-49.09%-85.57M23.10%-45.49M-2.83%-43.01M6.08%-204.62M9.53%-46.24M5.16%-57.4M2.49%-59.16M8.21%-41.82M
Depreciation and amortization 7.24%31.43M-21.69%6.66M-2.23%8.3M18.16%8.3M54.40%8.17M77.49%29.31M71.65%8.5M91.04%8.49M77.12%7.03M68.00%5.29M
Other non cash items 160.06%1.93M-12.69%1.47M54.80%-334K184.47%484K108.68%312K-144.33%-3.22M-90.50%1.69M77.23%-739K89.73%-573K-117.55%-3.59M
Change In working capital 1,627.35%15.41M-358.50%-1.14M4.55%12.56M287.27%3.46M104.58%532K81.16%-1.01M-82.53%441K141.12%12.02M20.36%-1.85M-10.17%-11.62M
-Change in receivables 295.46%8.44M-63.02%-2.95M-27.88%4M83.38%-657K296.63%8.06M55.10%-4.32M-373.72%-1.81M186.07%5.54M-117.98%-3.95M-101.67%-4.1M
-Change in inventory 10.33%7.99M2.77%4.41M-46.81%1.89M-89.60%486K122.74%1.2M196.05%7.24M15.89%4.29M129.35%3.56M207.45%4.68M37.40%-5.28M
-Change in prepaid assets 109.17%382K125.41%567K168.31%235K268.12%696K5.18%-1.12M-63.31%-4.17M-1,305.95%-2.23M74.12%-344K68.54%-414K-1,193.41%-1.18M
-Change in payables and accrued expense 147.13%485K-249.32%-2.65M356.13%5.54M270.58%3.98M-278.14%-6.38M-107.09%-1.03M-77.55%1.78M-80.16%1.22M-163.82%-2.33M46.98%-1.69M
-Change in other current assets -68.68%431K-112.58%-41K204.49%163K-98.73%9K-39.88%300K-81.08%1.38M-26.58%326K-105.28%-156K10.12%707K-84.56%499K
-Change in other current liabilities -2,045.37%-2.32M75.46%-468K-66.68%734K-99.06%-1.06M-1,312.70%-1.53M98.55%-108K81.62%-1.91M3.82%2.2M-161.20%-530K470.59%126K
Cash from discontinued investing activities
Operating cash flow 55.01%-64.09M26.00%-15.32M72.76%-6.38M56.14%-19.42M57.51%-22.97M-14.54%-142.47M-1,534.10%-20.7M31.39%-23.41M-4.60%-44.29M-15.90%-54.07M
Investing cash flow
Cash flow from continuing investing activities -106.07%-3.07M42.81%-1.29M-103.81%-711K-112.73%-5.24M159.75%4.17M121.73%50.61M-180.74%-2.25M348.47%18.67M409.61%41.16M96.92%-6.97M
Net PPE purchase and sale 81.73%-5.08M16.34%-2M78.60%-965K93.34%-603K87.26%-1.51M72.73%-27.78M85.46%-2.39M88.91%-4.51M71.68%-9.05M7.50%-11.82M
Net business purchase and sale --0------------------0----------------
Net investment purchase and sale -97.44%2.01M391.10%717K-98.90%254K-109.23%-4.64M16.86%5.67M166.91%78.39M-99.42%146K-48.27%23.18M168.86%50.21M102.36%4.85M
Cash from discontinued investing activities
Investing cash flow -106.07%-3.07M42.81%-1.29M-103.81%-711K-112.73%-5.24M159.75%4.17M121.73%50.61M-180.74%-2.25M348.47%18.67M409.61%41.16M96.92%-6.97M
Financing cash flow
Cash flow from continuing financing activities 656.31%6.89M720.59%3.63M539.94%2.91M19.87%1.83M-272.91%-1.47M-99.66%911K-64.35%442K49.58%-661K-99.44%1.53M60.93%-395K
Net issuance payments of debt --0------------------0----------------
Net common stock issuance 9.76%-3.98M99.29%-8K99.31%-7K-21.71%-1.54M-142.64%-2.42M-101.68%-4.41M30.50%-1.13M51.11%-1.01M-100.47%-1.26M60.95%-999K
Proceeds from stock option exercised by employees 104.38%10.87M131.23%3.64M725.78%2.92M20.70%3.36M57.45%951K-46.97%5.32M-45.15%1.57M-53.74%353K-15.29%2.79M-80.55%604K
Cash from discontinued financing activities
Financing cash flow 656.31%6.89M720.59%3.63M539.94%2.91M19.87%1.83M-272.91%-1.47M-99.66%911K-64.35%442K49.58%-661K-99.44%1.53M60.93%-395K
Net cash flow
Beginning cash position -23.93%289.28M-22.38%242.04M-22.47%246.22M-15.66%269.12M-23.93%289.28M-18.64%380.26M-17.46%311.84M-22.39%317.56M65.16%319.09M-18.64%380.26M
Current changes in cash 33.73%-60.28M42.34%-12.98M22.62%-4.18M-1,324.52%-22.84M66.99%-20.28M-4.81%-90.95M-916.73%-22.51M82.72%-5.4M-100.74%-1.6M77.60%-61.44M
Effect of exchange rate changes 566.67%126K252.08%73K100.63%2K-189.04%-65K-56.72%116K91.54%-27K84.91%-48K-204.76%-320K247.62%73K222.89%268K
End cash Position -20.79%229.13M-20.79%229.13M-22.38%242.04M-22.47%246.22M-15.66%269.12M-23.93%289.28M-23.93%289.28M-17.46%311.84M-22.39%317.56M65.16%319.09M
Free cash flow 59.37%-69.17M25.00%-17.32M73.70%-7.34M62.46%-20.03M62.85%-24.48M24.75%-170.25M-30.28%-23.1M62.66%-27.92M28.22%-53.34M-10.87%-65.89M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data